Spyglass Pharma

Aliso Viejo, United States

Spyglass Pharma provides medicine for ophthalmic diseases.

$75.0M raised

Jun 2025

Series D

Delivery Medical Pharmaceutical

Top Investors

New Enterprise AssociatesRA Capital ManagementSands Capital VenturesSamsara BioCapitalVensana Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Spyglass Pharma

How much funding has Spyglass Pharma raised?

Spyglass Pharma has raised $75.0M in total funding. The most recent round was Series D. The last funding was announced in June 2025.

Who are Spyglass Pharma's investors?

Spyglass Pharma's investors include New Enterprise Associates, RA Capital Management, Sands Capital Ventures, Samsara BioCapital, Vensana Capital.

Where is Spyglass Pharma headquartered?

Spyglass Pharma is headquartered in Aliso Viejo, United States.

What does Spyglass Pharma do?

Spyglass Pharma provides medicine for ophthalmic diseases.

What stage is Spyglass Pharma at?

Spyglass Pharma is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 2, 2025.

MLA

"Spyglass Pharma — Funding & Investors." VCBacked, June 2, 2025, https://www.vcbacked.co/company/spyglass-pharma. Accessed June 4, 2026.

APA

VCBacked. (2025). Spyglass Pharma — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/spyglass-pharma

Wikipedia (cite web)

{{cite web |title=Spyglass Pharma — Funding & Investors |url=https://www.vcbacked.co/company/spyglass-pharma |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 2, 2025.

Similar Companies in Delivery